NEW YORK, March 28 (GenomeWeb News) - Proteomics company Power3 Medical Products and New Horizons Diagnostics plan to use Power3's protein biomarkers to co-develop antibody-based diagnostics for neurodegenerative diseases, the firms said today.
Already have a GenomeWeb or 360Dx account?Login Now.
CNN reports that researchers have tied a new variant to opioid addiction risk.
Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.
An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.
In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.